| Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992) |
|---|
| 10/05/2006 | WO2005047460A3 Long-wavelength fps |
| 10/05/2006 | WO2005014778A3 Dna vaccine expressing ha1 of equine-2 influenza virus |
| 10/05/2006 | WO2004044163A3 Methods for identifying risk of melanoma and treatments thereof |
| 10/05/2006 | US20060222635 Methods and compositions for selecting cells with increased potency |
| 10/04/2006 | EP1707571A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 10/04/2006 | EP1706502A2 Methods and compositions for in vitro amplification of extrachromosomal nucleic acid |
| 10/04/2006 | EP1706483A2 Methods for culturing keratinocytes from human embryonic stem cells |
| 10/04/2006 | EP1644496A4 Modified vectors for organelle transfection |
| 10/04/2006 | EP1200606B1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| 10/04/2006 | EP1054955B1 Compositions comprising viruses and methods for concentrating virus preparations |
| 10/04/2006 | CN1842707A Prion protein binding materials and methods of use |
| 10/04/2006 | CN1842598A Glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate mutase regulatory sequences for gene expression in oleaginous yeast |
| 10/04/2006 | CN1842589A Systems and methods for separating and concentrating regenerative cells from tissue |
| 10/04/2006 | CN1840178A Tumour-specific animal proteins |
| 10/03/2006 | US7115398 Nucleotide sequences coding polypeptide for use in the treatment of bone disorders |
| 10/03/2006 | US7115263 Compositions and methods for treating hyperimmune response in the eye |
| 09/28/2006 | WO2005059109A3 Molecular signature of the pten tumor suppressor |
| 09/28/2006 | WO2005054434A3 Use of notch pathway interfering agents for treatment of plasma cell disorders |
| 09/28/2006 | WO2005052134A3 Ttbks as modifiers of the beta catenin pathway and methods of use |
| 09/28/2006 | WO2005042721A3 A method for altering the gender ratio of offspring in mammals by manipulation of spermatozoa |
| 09/28/2006 | US20060217534 Bis (amino acid) molecular scaffolds |
| 09/28/2006 | US20060217529 Method for Producing Insulin From a Natural Source and Insulin Produced by Said Method |
| 09/28/2006 | US20060216788 CASH (CASPASE HOMOLOGUE) with death effector domain, modulators of the function of FAS |
| 09/28/2006 | US20060216782 Methods for expression and purification of immunotoxins |
| 09/28/2006 | US20060216775 Compositions and methods for analysis and manipulation of enzymes in biosynthetic proteomes |
| 09/28/2006 | US20060216711 Variants of cytochrome c and methods of diagnosis of thrombocytopenia |
| 09/28/2006 | US20060216302 Immunological markers |
| 09/27/2006 | EP1611240A4 Interacts with ice1 and regulates cbf expression and freezing tolerance in arabidopsis |
| 09/27/2006 | EP1606304A4 Nucleotide sequences regulating gene expression and constructs and methods utilizing same |
| 09/27/2006 | EP1590489A4 Pretreatment method for extraction of nucleic acid from biological samples and kits therefor |
| 09/27/2006 | CN1839205A Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 09/27/2006 | CN1838962A Injection of bone marrow-derived cells and medium for angiogenesis |
| 09/26/2006 | US7112665 Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhibitors, DNA fragments and recombinants for use in the production of said cells and plants |
| 09/26/2006 | US7112421 Nucleic acids encoding BAFF receptor, chimeric proteins and methods and compositions related thereto |
| 09/26/2006 | US7112414 Masp-2, a complement-fixing enzyme, and uses for it |
| 09/21/2006 | WO2005059096A3 Methods for high fidelity production of long nucleic acid molecules with error control |
| 09/21/2006 | WO2005033271A3 METHODS OF RAPID DETECTION AND IDENTIFICATION OF BIOAGENTS USING microRNA |
| 09/21/2006 | WO2005026321A3 Protein o-sulfonation |
| 09/21/2006 | WO2005019412A3 Mucosal immunization to prevent prion infection |
| 09/21/2006 | WO2005001057A3 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 09/21/2006 | WO2004094616A3 Silencing transcription by methylation |
| 09/21/2006 | US20060212953 Tr2, tr4, tr2/tr4 double knockouts and uses thereof |
| 09/21/2006 | US20060211111 Compositions and methods for neural cell production and stabilization |
| 09/21/2006 | US20060210971 Pectate lyases, nucleic encoding them and methods for making and using them |
| 09/21/2006 | US20060210536 Methods and compositions for inhibiting stat signaling pathways |
| 09/20/2006 | EP1702064A2 A biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan |
| 09/20/2006 | EP1702063A2 Modulation of enzyme activity by changing reciprocal stereo-geometric positions of two catalytic centers in an enzyme |
| 09/20/2006 | CN1836050A Hairpin-labeled probes and methods of use |
| 09/20/2006 | CN1836048A Transducible DNA-binding proteins |
| 09/20/2006 | CN1276077C Short lactobacillus producing gamma-aminobutyric acid and use thereof |
| 09/19/2006 | US7109304 Humanized anti-CD19 antibodies |
| 09/19/2006 | US7109031 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 09/19/2006 | US7109021 Can be used for the treatment of diabetes or for delaying the onset of diabetes |
| 09/19/2006 | US7108997 Identifying myeloperoxidase modulator via decrease in hypochlorous acid conversion into chloramine; for treating nervous system, atherosclerotic, cancer, respiratory and inflammatory disorders |
| 09/19/2006 | US7108853 Surface protein of Leptospira |
| 09/14/2006 | WO2005047474A3 Nucleic acid detection method having increased sensitivity |
| 09/14/2006 | WO2004037192A3 Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases |
| 09/14/2006 | WO2004005462A3 Reagents and methods for identifying and modulating expression of tumor senescence genes |
| 09/14/2006 | US20060205932 Reacitng chitin with NaOH by suspending it in a nonsaponifiable, non-aqueous, water insoluble liquid having a flash point greater than about 100 degrees C |
| 09/14/2006 | US20060205686 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 09/14/2006 | US20060205072 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 09/14/2006 | US20060205071 Methods for ex-vivo expanding stem/progenitor cells |
| 09/14/2006 | US20060205038 antagonist antibody that blocks binding of IL-17; degenerative cartilaginous disorders and other inflammatory diseases |
| 09/14/2006 | US20060204964 Molecular detection systems utilizing reiterative oligonucleotide synthesis |
| 09/14/2006 | US20060204510 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 09/14/2006 | US20060204487 Production of high mannose proteins in plant culture |
| 09/14/2006 | US20060204480 Replication competent virus or its recombinant for use in cancer therapy |
| 09/13/2006 | EP1699934A2 Soluble analyte detection and amplification |
| 09/13/2006 | EP1699914A2 Novel sodium channel |
| 09/13/2006 | EP1699818A2 Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use |
| 09/13/2006 | EP1699485A2 Anti-hydroxylase antibodies and uses thereof |
| 09/13/2006 | EP1649010A4 Novel nucleic acids from sesame plants |
| 09/13/2006 | EP1623018A4 Mptens as modifiers of the pten/igf pathway and methods of use |
| 09/13/2006 | EP1502104A4 Comparative field analysis (comfa) utilizing topomeric alignment of molecular fragments |
| 09/13/2006 | EP1451365A4 Dna amplification and sequencing using dna molecules generated by random fragmentation |
| 09/13/2006 | CN1833021A Oligodendrocyte precursor cells and method of obtaining and culturing the same |
| 09/12/2006 | US7107155 Methods for the identification of genetic features for complex genetics classifiers |
| 09/12/2006 | US7104265 Filter containing a metal phthalocyanine and a polycationic polymer |
| 09/12/2006 | CA1341512C Methods for producing a t7-type dna polymerase |
| 09/08/2006 | WO2005047479A3 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast |
| 09/08/2006 | WO2005044975A3 Genes encoding carotenoid compounds |
| 09/08/2006 | WO2005033290A3 Methods for altering mrna splicing and treating familial dysautonomia and other mechanistically related disorders |
| 09/08/2006 | WO2005003307A3 Compositions and methods for analysis and manipulation of enzymes in biosynthetic proteomes |
| 09/08/2006 | WO2004085614A3 Nucleic acid molecules that are differentially regulated in a bipolar disorder and uses thereof |
| 09/07/2006 | US20060200872 Tobacco products with reduced nicotine |
| 09/07/2006 | US20060199264 Generating mammalian nervous system stem cells; obtain nervous system tissue, incubate with mitogen, monitor cells for differentiation into preferential tissues of nervous system |
| 09/07/2006 | DE112004001863T5 Verfahren und Verwendung von Bindungskomponenten zur Verbesserung der Testspezifität The method and use of binding components to improve the specificity test |
| 09/06/2006 | EP1697741A2 Methods of generating variant proteins with increased host string content and compositions thereof |
| 09/06/2006 | EP1697542A2 Compositions and methods of using apoptosis signaling kinase related kinase (askrk) |
| 09/06/2006 | EP1697534A2 Nucleic acid molecules containing recombination sites and methods of using the same |
| 09/06/2006 | EP1697525A2 P ef-tu expression units |
| 09/06/2006 | EP1697498A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 09/06/2006 | EP1697497A2 Liver cancer biomarkers |
| 09/06/2006 | EP1697396A2 Mrna transfected antigen presenting cells |
| 09/06/2006 | EP1697395A2 Chromosome 5 genetic variants related to dyslexia |
| 09/06/2006 | EP1696925A2 21-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 09/06/2006 | EP1696790A2 Apparatus and methods for assessing metabolic substrate utilization |
| 09/06/2006 | EP1648999A4 Systems and methods for separating and concentrating regenerative cells from tissue |
| 09/06/2006 | EP1594376B1 Filter containing a metal phthalocyanine and a polycationic polymer |
| 09/06/2006 | CN1829800A Metabolically engineered bacterial strains having enhanced 2-keto-D-gluconate accumulation |